chitosan has been researched along with Cardiotoxicity in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, H; Jeon, S; Kim, K; Lee, S; Shim, MK; Yhee, JY; Yoon, HY | 1 |
| Luo, X | 1 |
| Abo Mansour, HE; Abo-Elmatty, DM; Badawy, NS; El-Batsh, MM; Mehanna, ET; Mesbah, NM | 2 |
| Kazem, A; Nafee, N; Nasr, M; Saad, H | 1 |
1 review(s) available for chitosan and Cardiotoxicity
| Article | Year |
|---|---|
Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity.
Topics: Antineoplastic Agents; Cardiotoxicity; Cardiovascular Diseases; Chitosan; Heart Diseases; Humans; Neoplasms; Pharmaceutical Preparations | 2023 |
4 other study(ies) available for chitosan and Cardiotoxicity
| Article | Year |
|---|---|
In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity.
Topics: Animals; Cardiotoxicity; Chitosan; Drug Delivery Systems; Mice; Nanoparticles; Neoplasms | 2023 |
Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Diethylnitrosamine; Doxorubicin; Drug Combinations; Drug Delivery Systems; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Malondialdehyde; Mice; Myocardium; Nanoparticles; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Verapamil | 2020 |
Ginger Extract Loaded into Chitosan Nanoparticles Enhances Cytotoxicity and Reduces Cardiotoxicity of Doxorubicin in Hepatocellular Carcinoma in Mice.
Topics: Animals; Carcinoma, Hepatocellular; Cardiotoxicity; Chitosan; Doxorubicin; Liver Neoplasms; Male; Mice; Nanoparticles; Plant Extracts; Vascular Endothelial Growth Factor A; Zingiber officinale | 2021 |
Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Disease Models, Animal; Drug Delivery Systems; Epirubicin; Glutathione; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Lipid Peroxidation; Liver; Liver Neoplasms; Mice; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Superoxide Dismutase; Tocotrienols; Tumor Suppressor Protein p53 | 2014 |